These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 18368615

  • 1. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC, Montebello ME, Dyer KR, Quigley A, Blaszczyk J, Tomkins S, Shand D.
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [Abstract] [Full Text] [Related]

  • 2. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual.
    McGregor C, Srisurapanont M, Mitchell A, Wickes W, White JM.
    J Subst Abuse Treat; 2008 Oct; 35(3):334-42. PubMed ID: 18329221
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M, Wickes W, Smout M, Harrison S, Cahill S, White JM.
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [Abstract] [Full Text] [Related]

  • 4. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M, Gama CS, Sundram S, Hustig H, Koopowitz L, D'Souza R, Malloy H, Rowland C, Monkhouse A, Monkhouse A, Bole F, Sathiyamoorthy S, Piskulic D, Dodd S.
    Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
    [Abstract] [Full Text] [Related]

  • 5. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.
    Pahwa R, Lyons KE.
    Mov Disord; 2003 May; 18(5):584-7. PubMed ID: 12722174
    [Abstract] [Full Text] [Related]

  • 6. The effect of mirtazapine in patients with chronic pain and concomitant depression.
    Freynhagen R, Muth-Selbach U, Lipfert P, Stevens MF, Zacharowski K, Tölle TR, von Giesen HJ.
    Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
    [Abstract] [Full Text] [Related]

  • 7. An open-label study of mirtazapine as treatment for combat-related PTSD.
    Alderman CP, Condon JT, Gilbert AL.
    Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388
    [Abstract] [Full Text] [Related]

  • 8. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, Brady D, McKetin R, Mattick RP, Wodak A.
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [Abstract] [Full Text] [Related]

  • 10. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
    Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A.
    Biol Psychiatry; 2006 Jun 01; 59(11):1071-7. PubMed ID: 16497273
    [Abstract] [Full Text] [Related]

  • 11. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
    Varia I, Venkataraman S, Hellegers C, Gersing K, Doraiswamy PM.
    Psychopharmacol Bull; 2007 Jun 01; 40(1):47-56. PubMed ID: 17285095
    [Abstract] [Full Text] [Related]

  • 12. The nature, time course and severity of methamphetamine withdrawal.
    McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM.
    Addiction; 2005 Sep 01; 100(9):1320-9. PubMed ID: 16128721
    [Abstract] [Full Text] [Related]

  • 13. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I, Shamir D, Bar-Hamburger R, Pick CG, Schreiber S.
    Addict Behav; 2005 Jul 01; 30(6):1154-67. PubMed ID: 15925125
    [Abstract] [Full Text] [Related]

  • 14. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
    Liappas J, Paparrigopoulos T, Tzavellas E, Rabavilas A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan 01; 29(1):55-60. PubMed ID: 15610945
    [Abstract] [Full Text] [Related]

  • 15. Mirtazapine improves alcohol detoxification.
    Liappas J, Paparrigopoulos T, Malitas P, Tzavellas E, Christodoulou G.
    J Psychopharmacol; 2004 Mar 01; 18(1):88-93. PubMed ID: 15107190
    [Abstract] [Full Text] [Related]

  • 16. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul 01; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
    Altintoprak AE, Zorlu N, Coskunol H, Akdeniz F, Kitapcioglu G.
    Hum Psychopharmacol; 2008 Jun 01; 23(4):313-9. PubMed ID: 18327889
    [Abstract] [Full Text] [Related]

  • 18. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 Jun 01; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
    Poyurovsky M, Epshtein S, Fuchs C, Schneidman M, Weizman R, Weizman A.
    J Clin Psychopharmacol; 2003 Jun 01; 23(3):305-8. PubMed ID: 12826992
    [Abstract] [Full Text] [Related]

  • 20. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J, Prochazka J, Odén A, Sjödin I, Dahl ML, Ahlner J, Bengtsson F.
    Hum Psychopharmacol; 2006 Apr 01; 21(3):151-8. PubMed ID: 16444795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.